Biopharma Business

Tag "brittle bone disease drug"

Mereo’s brittle bone drug joins EU’s adaptive pathways scheme

UK-based rare and speciality diseases group Mereo BioPharma says its brittle bone disease drug BPS-804 has been accepted to participate in the European Medicines Agency’s (EMA) Adaptive Pathways programme. The

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here